CI — Cell Impact AB (publ) Income Statement
0.000.00%
- SEK148.80m
- SEK145.09m
- SEK47.26m
Annual income statement for Cell Impact AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12 | 29.3 | 81.8 | 76.8 | 47.3 |
Cost of Revenue | |||||
Gross Profit | -21.9 | -7.26 | -5.43 | -5.58 | -14.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 59.4 | 72.4 | 160 | 180 | 167 |
Operating Profit | -47.4 | -43.1 | -78 | -103 | -119 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -48.4 | -44.3 | -79.7 | -104 | -121 |
Provision for Income Taxes | |||||
Net Income After Taxes | -48.4 | -44.3 | -79.9 | -104 | -121 |
Net Income Before Extraordinary Items | |||||
Net Income | -48.4 | -44.3 | -79.9 | -104 | -121 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -48.4 | -44.3 | -79.9 | -104 | -121 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.316 | -0.261 | -0.427 | -0.436 | -0.205 |
Dividends per Share |